Southwest oncology group strategies in prostatic carcinoma

E. David Crawford, Maha Hussain, Edward P. Deantoni, Ian M. Thompson, Mario A. Eisenberger, Brent Blumenstein, Charles A. Coltman

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

The Southwest Oncology Group Genitourinary Committee evolved in 1978 from a combined gynecologie‐urologie cancer committee. A significant catalyst in this development was the growing interest in prosta‐tic carcinoma, with an initial focus on hormone refractory disease. Clinical studies have expanded into combined androgen blockade, untreated metastatic disease and localized prostate cancer. Since 1978, more than forty trials in prostatic carcinoma have been conducted. Currently, seven are in progress or under development. Conclusions and future directions are reviewed. © 1995 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)60-64
Number of pages5
JournalSeminars in Surgical Oncology
Volume11
Issue number1
DOIs
StatePublished - 1995

Keywords

  • advanced disease
  • clinical trials
  • prostate cancer

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Southwest oncology group strategies in prostatic carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Crawford, E. D., Hussain, M., Deantoni, E. P., Thompson, I. M., Eisenberger, M. A., Blumenstein, B., & Coltman, C. A. (1995). Southwest oncology group strategies in prostatic carcinoma. Seminars in Surgical Oncology, 11(1), 60-64. https://doi.org/10.1002/ssu.2980110109